Autophagy captures and degrades intracellular proteins and organelles in lysosomes ([@R17]). The autophagy pathway was first identified by yeast genetic approaches to confer survival to nitrogen starvation. Later it became apparent that newborn mice also require autophagy to survive starvation ([@R13]; [@R11]). Thus, autophagy is an intracellular nutrient scavenging pathway whereby cells eat parts of themselves and presumably recycle the breakdown products, to sustain survival in starvation.

Basal levels of autophagy are normally low but are profoundly induced by stress and starvation, indicating that rapid autophagy mobilization is part of the integrated stress response ([@R18]). Genetic ablation of autophagy in various settings causes the accumulation of autophagy substrates, particularly damaged proteins and organelles such as abnormal mitochondria ([@R17]). Thus, autophagy is needed for metabolic homeostasis and for protein and organelle quality and numerical control. Without autophagy, survival to stress is compromised, and cells and tissues are subjected to the toxic effects of vast accumulation of autophagy substrates. Because the levels of half the cellular proteins are affected by the functional status of autophagy, this pathway represents a major mechanism for protein turnover and homeostasis ([@R15], [@R16]).

Unlike normal cells, tumor cells can have high levels of basal autophagy and can be constitutively dependent on autophagy for survival ([@R3]; [@R5]; [@R24]). Autophagy is also induced in hypoxic tumor regions and confers a survival advantage ([@R3]). These findings suggest that autophagy inhibition may compromise tumor survival and may be a new approach ripe to target for cancer therapy ([@R1], [@R2]). Indeed, genetically engineered mouse models (GEMMs) for cancer where essential autophagy genes are ablated show the functional importance of autophagy for various aspects of tumorigenesis ([@R2]). Autophagy in these GEMMs for cancer promotes the growth, survival, and malignancy of a broad spectrum of cancers that was reviewed in detail recently ([@R1]). Herein we provide an overview and discuss the settings and underlying mechanisms by which autophagy promotes tumorigenesis.

AUTOPHAGY IS REQUIRED FOR MAMMALIAN SURVIVAL {#S1}
============================================

First insight into the role of autophagy in sustaining mammalian survival came from studies where an essential autophagy gene was deleted in mice. These mice are born but fail to survive the neonatal starvation period ([@R13]; [@R11]). Feeding autophagy-deficient neonatal mice extends survival only briefly indicating that autophagy is essential for mammalian survival to neonatal starvation but also generally. In contrast, adult mice subjected to conditional whole-body deletion of an essential autophagy gene live for 2--3 months, indicating that adult mice are less autophagy-dependent than neonates ([@R10]). Adult mice are physiologically and metabolically different from neonates and possess dedicated nutrient stores that may reduce autophagy dependence. Fasting these adult mice without autophagy, however, is lethal ([@R10]). Thus, the main function of autophagy conserved from yeast to mammals is to confer survival to starvation.

How does autophagy promote survival to starvation at the cellular and organismal level? During fasting, normal adult mice activate autophagy at the cellular level to sustain cell survival and they mobilize nutrient stores at the organismal level to sustain circulating nutrients essential for survival ([@R10]). For example, glycogen is degraded to generate circulating glucose ([Fig. 1](#F1){ref-type="fig"}). Lipid in white adipose tissue (WAT) is also degraded to produce glycerol and fatty acids that are used as substrates for ketogenesis and gluconeogenesis in the liver ([Fig. 1](#F1){ref-type="fig"}). With prolonged starvation, muscle protein is degraded to produce amino acids for use by the liver to synthesize ketone bodies and glucose. This prioritized mobilization of circulating nutrients is aimed at maintaining circulating substrates for brain metabolism, the absence of which is fatal ([Fig. 1](#F1){ref-type="fig"}).

In contrast, adult mice without autophagy owing to conditional deletion of the essential autophagy gene *Atg7* have a systemic metabolic defect that is fatal during fasting ([@R10]). The inability to activate autophagy at the cellular level causes rapid depletion of glycogen and WAT lipid stores, and extensive muscle catabolism (cachexia) ([Fig. 1](#F1){ref-type="fig"}). The accelerated depletion of nutrient stores causes autophagy-deficient mice to fail to maintain circulating glucose levels, resulting in death within 16 h from hypoglycemia ([@R10]). Autophagy in the liver appears necessary to sustain circulating glucose levels and brain function ([@R4]; [@R10]). Thus, autophagy in mammals is essential to supply circulating nutrients for systemic metabolism during fasting. The inability of cells to use autophagy may create a systemic metabolic deficit, accelerating catabolism of nutrient stores ([@R10]). Alternatively, autophagy may be directly involved in the secretion of essential metabolic substrates into the circulation, the absence of which increases dependency on nutrient stores. These findings also raise the interesting possibility that suppression of autophagy may promote cachexia, a significant medical problem for advanced cancer patients ([@R10]).

As autophagy is essential for glucose homeostasis in fasted adult mice, is there a role also in the fed state? A small fraction of the adult mice conditionally deleted for *Atg7* die soon after deletion from streptococcus infection ([@R10]). In in vitro experiments autophagy plays a role in host defense by eliminating intracellular bacteria including streptococcus, and this finding indicates that this may also be relevant in vivo. Most adult mice conditionally deleted for *Atg7* die 2--3 months postdeletion ([@R10]). This contrasts neonatal mice that fail to tolerate *Atg7* deletion ([@R13]; [@R11]). Neurodegeneration is the main cause of death of *Atg7* conditionally ablated adult mice ([@R10]), which is not surprising given that autophagy deficiency targeted to the brain also causes neurodegeneration ([@R8]; [@R12]). What is surprising is that neurodegeneration upon conditional deletion of *Atg7* in the whole body is greatly accelerated in comparison to tissue-specific deletion ([@R10]). This suggests that autophagy deficiency in non-neuronal tissues also contributes to neurodegeneration, perhaps through defective systemic metabolism. These *Atg7*-ablated adult mice have a deficit in circulating arginine levels, and it will be of great interest to explore if this contributes to the neurodegeneration phenotype ([@R10]). Another important unanswered question is why tissues like the brain are more autophagy-dependent than other tissues, such as lung. In summary, switching off autophagy in adult mice is tolerated for weeks in the fed state.

AUTOPHAGY PROMOTES TUMORIGENESIS IN GEMMs FOR CANCER {#S2}
====================================================

The first clue that autophagy is important for the survival of tumor cells came from the observation that, in stark contrast to normal cells, some cancer cells have high levels of basal autophagy ([@R5]; [@R24]). Up-regulation of autophagy in cancer cells is caused by direct activation of the transcription factors of the microphthalmia-associated transcription factor (MiTF)/TFE family that control autophagy and lysosomal biogenesis or by removal of a repressive phosphorylation on the autophagy initiation machinery ([@R19]; [@R23]). Moreover, deletion of an essential autophagy gene compromises the survival of those tumor cells in vitro and in tumors in vivo ([@R5]; [@R24]). This prompted many laboratories to examine the role of autophagy in GEMMs for cancer where essential autophagy genes are deleted in tumor cells arising spontaneously in the context of a functional immune system. In most of these models, loss of autophagy reduces tumor growth, survival, and proliferation ([@R2]). In models of K-ras-driven lung and pancreatic cancer, loss of autophagy limits tumor progression to benign disease, which is attributed in part to amplified activation of p53. The requirement for autophagy for tumor growth and survival is also apparent with p53 deletion. In lung cancer GEMMs, deletion of *Atg7* dramatically alters tumor pathology from carcinomas to that of benign oncocytomas, which are human tumors that massively accumulate defective mitochondria ([@R6]; [@R21]). As defective mitochondria are a major autophagy substrate, this indicates that benign human tumors manifest a phenotype of defective autophagy, perhaps explaining their benign status. Indeed, genomic and biological characterization of human renal oncocytomas revealed a metabolic defect stemming from pathogenic mitochondrial genome mutations and defective intracellular trafficking, lysosome, and autophagy function ([@R9]). These benign tumors represent a natural setting where tumor progression is halted due to deficient metabolism, which can be caused by loss of mitochondrial energy homeostasis and quality control.

TUMORS ARE MORE AUTOPHAGYDEPENDENT THAN MOST NORMAL TISSUES {#S3}
===========================================================

These collective findings suggest that autophagy inhibition may be a therapeutic approach for some cancers ([@R2]). As autophagy is important for some normal tissues, this raised the question as to whether the selective dependency of tumors on autophagy is sufficient to produce a therapeutic window. To address this, the essential autophagy gene *Atg7* was deleted conditionally in the whole body of mice with established K-ras-driven lung cancer. Conditional, systemic autophagy loss has remarkable antitumor activity, more so than tumor-specific loss ([@R10]). This suggests that host autophagy in addition to tumor cell autonomous autophagy contributes to tumor growth. Indeed, stromal cell autophagy in models of pancreatic cancer leads to secretion of alanine that is used by tumor cells as metabolic fuel ([@R20]). Blockade of this tumor metabolism-promoting metabolic cross talk between stroma and tumor is an additional anticancer benefit of autophagy inhibition ([@R2]). Whether systemic autophagy beyond stroma also contributes to tumor growth remains to be explored.

AUTOPHAGY RECYCLES MACROMOLECULES {#S4}
=================================

Although the experiments above begin to address the role of autophagy in sustaining whole-body mammalian metabolism, what happens at the cellular level is still an open question. How does autophagy promote survival of cells in starvation? Is this through recycling of cellular components? Do cancer cells do this differently from normal cells and tissues? To begin to address these points we developed an assay to directly measure autophagy-mediated recycling of macromolecules into cancer cell metabolism to find out whether recycling occurs, and if so, what it is used for.

Cancer cells derived directly from the tumors arising in the GEMMs for lung cancer are autophagy dependent as isogenic *Atg7*-deficient tumor cells are more sensitive to starvation than *Atg7* wild-type tumor cells ([@R6]; [@R21]). To address why autophagy deficiency causes sensitivity to starvation, individual nutrients were added back to determine which were essential for survival. We found that glutamine supplementation in starvation conditions is most effective at rescuing the survival of autophagy-deficient tumor cells ([@R6]; [@R21]). Because glutamine is a major anapleurotic substrate for the tricarboxylic acid (TCA) cycle ([@R25]), this suggests that autophagy may recycle intracellular macromolecules to provide amino acid substrates such as glutamine to maintain mitochondrial function ([Fig. 2](#F2){ref-type="fig"}). To test this hypothesis, macromolecules of *Atg7* wild-type and deficient tumor cells were stably labeled with heavy isotopes of carbon and nitrogen. The label was then briefly chased out of metabolic pathways with cold media, and then the cells were challenged with starvation to force autophagy-mediated recycling specifically in the *Atg7* competent cells and not in the *Atg7*-deficient cells. Reappearance of heavy isotope labeled metabolites into central carbon metabolism was then assessed by liquid chromatography and mass spectrometry ([@R7]).

Upon challenge with starvation, labeled metabolites were enriched in the *Atg7* competent compared with deficient tumor cells, particularly in TCA cycle intermediates and amino acids synthesized in mitochondria ([@R7]). What surprised us was that labeling of metabolism was also apparent in the *Atg7*-deficient tumor cells, although it was significantly less than *Atg7* wild-type cells. This indicates that autophagy does recycle macromolecules in starvation, that this is specific to mitochondrial metabolism, but that there also exists autophagy-independent mechanisms for recycling ([@R7]). What those autophagy-independent mechanisms of recycling are is not known but proteasome-mediated or other forms of lysosome-mediated degradation may be responsible.

AUTOPHAGY-MEDIATED RECYCLING PROMOTES CANCER METABOLISM {#S5}
=======================================================

If autophagy is degrading macromolecules in starvation to supply substrates for mitochondrial metabolism, what are the substrates used for? Isotope tracing helped answer this question. Carbon flux from glutamine is accelerated in *Atg7*-deficient tumor cells in starvation where it flows from the TCA cycle to pyruvate and to aspartate ([Fig. 3](#F3){ref-type="fig"}). Using glutamine carbon to synthesize pyruvate can produce nicotinamide adenine dinucleotide phosphate (NADPH) via malic enzyme for use in generating reduced glutathione for antioxidant defense ([@R7]). Aspartate is a major biosynthetic product of oxaloacetate (OAA) from the TCA cycle and is a precursor for de novo nucleotide biosynthesis ([@R7]). Finally, the general supply of substrates to mitochondria through autophagy can drive energy production ([@R7]). These findings pointed to a role for autophagy-supplied mitochondrial substrates in redox homeostasis, nucleotide biosynthesis, and energy homeostasis ([Fig. 4](#F4){ref-type="fig"}).

*Atg7* deficiency increases reactive oxygen species (ROS), which is extinguished by glutamine supplementation in starvation ([@R7]). Scavenging ROS, however, fails to rescue survival of starved *Atg7*-deficient tumor cells. Thus, autophagy-supplied substrates function in maintaining redox homeostasis, although restoring redox balance alone is insufficient to rescue survival in starvation.

Starving *Atg7*-deficient tumor cells severely depletes nucleotide pools, particularly adenosine nucleotides, consistent with a requirement for autophagy to supply substrates for aspartate and de novo nucleotide synthesis ([@R7]). Supplementation of autophagy-deficient tumor cells with nucleosides during starvation rescues survival, indicating that autophagy prevents fatal nucleotide pool depletion. In starvation, autophagy also prevents loss of mitochondrial respiration, ATP loss and AMP accumulation, and AMP kinase activation ([@R7]). Thus, a major function of autophagy is to supply substrates for mitochondrial metabolism to maintain energy homeostasis.

The depletion of nucleotide pools and energy crisis in starved autophagy-deficient tumor cells may be related. In yeast, autophagy loss also causes AMP accumulation and energy crisis in starvation, triggering AMP degradation to escape energy crisis in the short term ([@R22]). In tumor cells, as in yeast, the requirement for autophagy to supply substrates for de novo nucleotide synthesis in starvation may also be caused by energy crisis and AMP degradation as a means to escape energy crisis ([Fig. 4](#F4){ref-type="fig"}). Indeed, nucleotide degradation products accumulate to high levels in starved *Atg7*-deficient but not *Atg7* wild-type tumor cells ([@R7]). Autophagy therefore becomes essential to provide metabolic substrates to prevent energy crisis upon nutrient deprivation and thereby the subsequent nucleotide pool depletion.

CONCLUSION {#S6}
==========

From the study of genetically engineered mice, it is clear that autophagy is important for systemic adult mammalian metabolism. During fed conditions, autophagy is less critical, conferring loss of WAT, select tissue damage, susceptibility to infection, and neurodegeneration after 2--3 months. Autophagy is, however, critical to prevent fatal hypoglycemia during fasting. We discovered that autophagy is a component of nutrient sharing among tissues, as rapid depletion of WAT and glycogen in mice with conditional loss of *Atg7* is also associated with excessive muscle catabolism. The metabolic defect at the cellular level creates a systemic metabolic deficit, accelerating exhaustion of nutrient stores and compensatory destruction of muscle, which is ultimately fatal.

Many tumors up-regulate autophagy transcriptionally and posttranscriptionally and depend on it for macromolecular recycling and survival, a requirement that is particularly acute in stress in the tumor microenvironment and during starvation. Indeed, the antitumor activity of caloric restriction is enhanced by deficiency in autophagy ([@R14]). In K-ras-driven non--small cell lung cancer, macromolecular recycling by autophagy suppresses oxidative stress, but preventing energy crisis and nucleotide pool depletion are essential for survival to stress. As some tumors are more autophagy-dependent than most normal tissues, it will be important to determine the therapeutic utility of autophagy inhibition in cancer therapy ([@R2]).
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![Mechanism by which autophagy promotes the survival of adult mice during fasting. During fasting, healthy adult mice activate autophagy and degrade glycogen to maintain circulating glucose and mobilize lipid stores to produce glycerol and fatty acids for ketogenesis and gluconeogenesis. As a last resort, muscle degradation by atrophy-associated E3 ligases may supply amino acids for ketogenesis and gluconeogenesis ([@R10]). As a result, glucose homeostasis is maintained by autophagy in mice to surviving fasting. However, fasting adult mice with acute autophagy ablation causes excessive depletion of nutrient stores including lipid and glycogen, accelerated muscle catabolism, and liver damage, which causes severe systemic hypoglycemia, brain damage, and mouse death. (Modified, with permission, from [@R10], © AACR.)](nihms882804f1){#F1}

![Defective autophagy in tumor cells alters metabolic flux from glutamine to aspartate and to de novo nucleotide synthesis. K-ras-driven tumor cells depend on autophagy to supply the substrate glutamine and its derivatives to sustain mitochondria metabolism for starvation survival. To compensate, *Atg7*-deficient tumor cells significantly increase glutamine flux to the tricarboxylic acid (TCA) cycle, de novo nucleotide synthesis, and nicotinamide adenine dinucleotide phosphate (NADPH) generation by up-regulating flux from malate, pyruvate, acetyl-CoA, and citrate for antioxidant defense ([@R7]). OAA, oxaloacetate; α-KG, α-ketogluturate.](nihms882804f2){#F2}

![Autophagy recycles macromolecules to provide mitochondrial substrates for nucleotide synthesis and energy homeostasis. Tumor cells rely on mitochondria metabolism for their proliferation and tumorigenesis. In starvation, autophagy is essential to mediate substrate recycling to supply tricarboxylic acid (TCA)-associated amino acids, which are further metabolized through the TCA cycle for energy production and de novo nucleotide biosynthesis. OAA, oxaloacetate; ETC, electron transport chain.](nihms882804f3){#F3}

![Autophagy-supplied substrates prevent energy crisis and fatal nucleotide depletion. Substrates derived from autophagy are required to generate ATP via tricarboxylic acid (TCA) cycle--driven oxidative phosphorylation in starvation. In the absence of autophagy, defective de novo nucleotide synthesis and increased nucleotide degradation cause nucleotide pool depletion and cell death.](nihms882804f4){#F4}
